Randall J. Lanham serves as Executive at NYMOX PHARMACEUTICAL CORP, where they oversee executive responsibilities. Since joining the company, Randall J. Lanham has executed 1 insider transactions totaling $5.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 28, 2018 involved purchasing 2,900 shares valued at $5.0K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Oct 28, 2018 | NYMX | $5.0K | Purchase | 2,900 | $1.72 | Discretionary |
Randall J. Lanham currently holds 152,900 shares of NYMOX PHARMACEUTICAL CORP (NYMX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Randall J. Lanham has been a net buyer of NYMX stock. They have purchased $5.0K and sold $0 worth of shares.
Randall J. Lanham's most recent insider trade was on Oct 28, 2018, when they purchased 2,900 shares at $1.72 per share.
Get notified when new Form 4 filings are submitted